Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2833511
Reference Type
Journal Article
Title
Far-infrared therapy for cardiovascular, autoimmune, and other chronic health problems: A systematic review
Author(s)
Shui, S; Wang, X; Chiang, JY; Zheng, L
Year
2015
Is Peer Reviewed?
Yes
Journal
Experimental Biology and Medicine
ISSN:
1535-3702
EISSN:
1535-3699
Volume
240
Issue
10
Page Numbers
1257-1265
Language
English
PMID
25716016
DOI
10.1177/1535370215573391
Web of Science Id
WOS:000362190300001
Relationship(s)
has retraction
10503743
Retraction Notice: Shanshan Shui, Xia Wang, John Y Chiang and Lei Zheng. Far-infrared therapy for cardiovascular, autoimmune, and other chronic health problems
Abstract
Physical therapy (physiotherapy), a complementary and alternative medicine therapy, has been widely applied in diagnosing and treating various diseases and defects. Increasing evidence suggests that convenient and non-invasive far-infrared (FIR) rays, a vital type of physiotherapy, improve the health of patients with cardiovascular disease, diabetes mellitus, and chronic kidney disease. Nevertheless, the molecular mechanisms by which FIR functions remain elusive. Hence, the purpose of this study was to review and summarize the results of previous investigations and to elaborate on the molecular mechanisms of FIR therapy in various types of disease. In conclusion, FIR therapy may be closely related to the increased expression of endothelial nitric oxide synthase as well as nitric oxide production and may modulate the profiles of some circulating miRNAs; thus, it may be a beneficial complement to treatments for some chronic diseases that yields no adverse effects.
Keywords
Physical therapy; far-infrared (FIR); cardiovascular disease (CVD); diabetes mellitus (DM); miRNA
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity